8-K 1 j0090101e8vk.txt MYMETICS CORP. UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): May 5, 2003 MYMETICS CORPORATION (Exact name of Registrant as specified in its charter) DELAWARE (State of Incorporation) 000-25132 25-1741849 (Commission File Number) (I.R.S. Employer Identification No.) 150 CHESTNUT STREET PROVIDENCE, RHODE ISLAND 02903 (Address of principal executive offices) 706 GIDDINGS AVENUE, SUITE 1 C ANNAPOLIS, MARYLAND 21401-1472 (Former Address) 50-52 AVENUE DU CHANOINE CARTELLIER 69230 SAINT-GENIS LAVAL, FRANCE (Former Address) 401-861-7604 (Registrant's telephone number, including area code) ITEM 5. OTHER EVENTS. On May 5, 2003, Dr. Pierre Francois Serres was terminated as our Chief Scientific Officer. On April 22, 2003, our board of directors gave Dr. Serres notice that he was, in various respects, in breach of his employment agreement. Pursuant to the employment agreement, Dr. Serres was given an opportunity to cure such breaches. The breaches were not cured and Dr. Serres' employment with us was terminated effective May 5, 2003. Dr. Serres is still a member of our board of directors. SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Date: May 8, 2003 MYMETICS CORPORATION By: /s/ John Musacchio -------------------- John Musacchio, Chief Financial Officer, Secretary and Director